Other inflammation-regulatory effects of PCSK9i have been described in population with FH, such as enhanced activation of T-regulatory cells, increased anti-inflammatory mediators like IL-10, reduction of pro-inflammatory cytokines and impairment in leukocyte attachment to endothelium (9). This evidence concerns the gene IL10 and familial hyperaldosteronism.